Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient mice

Molecular Brain Research

Volumn 80, Issue 1, 2000, Pages 1-6

  Tseng, Kuei Y ^a   Roubert, Christine ^b   Do, Louis ^b   Rubinstein, Marcelo ^c   Kelly, Michele A ^d   Grandy, David K ^d   Low, Malcolm J ^d   Gershanik, Oscar S ^e   Murer, M Gustavo ^a   Giros, Bruno ^b   Raisman Vozari, Rita ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Dopamine receptors; Nurr1; Substantia nigra

Indexed keywords

AUTORECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE AUTORECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; IN SITU HYBRIDIZATION; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA;

ANIMALS; DNA-BINDING PROTEINS; IN SITU HYBRIDIZATION; MESENCEPHALON; MICE; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS;

EID: 0034233576     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00107-8     Document Type: Article

References (29)

1. 125I]-iodosulpiride. Neuroscience. 20:1987;117-155.
2. Castillo S.O., Xiao Q., Lyu M.S., Kozak C.A., Nikodem V.M. Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. Genomics. 41:1997;250-257.
3. Castillo S.O., Baffi J.F., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of Nurr1 gene. Mol. Cell. Neurosci. 11:1998;36-46.
4. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 32:1993;281-307.
5. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Cragg S.J., Greenfield S.A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17:1997;5738-5746.
7. Dickinson S.D., Sabeti J., Larson G.A., Giardina K., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Gerhardt G.A., Zahniser N.R. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72:1999;148-156.
8. Gangolly E.A., Conneely O.M., O'Malley B.W. Neurotransmitters activate the human estrogen receptor in a neuroblastoma cell line. J. Steroid Mol. Biol. 61:1997;1-9.
9. Groves P.M., Wilson C.J., Young S.J., Rebec G.V. Self inhibition by dopaminergic neurons. Science. 190:1975;522-529.
10. Ichinose H., Ohye T., Suzuki T., Sumi-Ichinose C., Nomura T., Hagino Y., Nagatsu T. Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. Gene. 230:1999;233-239.
11. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., Bunzow J.R., Fang Y., Gerhardt G.A., Grandy D.K., Low M.J. Locomotor activity in D2 dopamine receptor-deficient mice is determined by genetic dosage, genetic background, and developmental adaptations. J. Neurosci. 18:1998;3470-3479.
12. Kung M.P., Chumpradit S., Frederick D., Garner S., Burris K.D., Molinoff P.B., Kung H. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;611-617.
13. Law S.W., Conneely O.M., DeMayo F.J., O' Malley B.W. Identification of a new brain specific transcription factor, Nurr1. Mol. Endocrinol. 6:1992;2129-2135.
14. Meiergerd S.M., Patterson T.A., Schenk J.O. D2 receptors modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61:1993;764-767.
15. Mercuri N.B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G., Borrelli E. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience. 79:1997;323-327.
16. O'Hara C.M., Uhland-Smith A., O' Malley K.L., Todd R.D. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors. J. Pharmacol. Exp. Ther. 277:1996;186-192.
17. Pothos E.N., Przedborski S., Davila V., Schmitz Y., Sulzer D. D2-like dopamine autoreceptor activation reduces quantal size in PC12 cells. J. Neurosci. 18:1998;5575-5585.
18. Power R.F., Lydon J.P., Conneely O.M., O'Malley B.W. Dopamine activation of an orphan of the steroid receptor superfamily. Science. 252:1991;1543-1546.
19. Sakurada K., Ohshima-Sakurada M., Palmer T.D., Gage F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development. 126:1999;4017-4026.
20. Saucedo-Cardenas O., Conneely O.M. Comparative distribution of Nurr1 and Nurr77 nuclear receptors in the mouse central nervous system. J. Mol. Neurosci. 7:1996;51-63.
21. Saucedo-Cardenas O., Kardon R., Ediger T.R., Lydon J.P., Conneely O.M. Cloning and structural organization of the gene encoding the murine nuclear receptor transcription factor Nurr1. Gene. 187:1997;135-139.
22. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA. 95:1998;4013-4018.
23. Swarzenski B.C., Tang L., Oh Y.J., O'Malley K.L., Todd R.D. Morphogenetic potentials of D2, D3 and D4 dopamine receptors revealed in transfected neuronal cell lines. Proc. Natl. Acad. Sci. USA. 91:1994;649-653.
24. Tang L., Todd R.D., Heller A., O'Malley K.L. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268:1994;495-502.
25. Tepper J.M., Sun B.-C., Martin L.P., Creese I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci. 17:1997;2519-2530.
26. Torii T., Kawarai T., Nakamura S., Kawakami H. Organization of the human orphan nuclear receptor Nurr1 gene. Gene. 230:1999;225-232.
27. Vila M., Levy R., Herrero M.-T., Ruberg M., Faucheux B., Obeso J.A., Agid Y., Hirsch E.C. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and non-human primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci. 17:1997;765-773.
28. Zetterström R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopaminergic system. Mol. Brain Res. 41:1996;111-120.
29. Zetterström R.H., Solomin L., Jansson L., Hoffer H.J., Olson L., Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 276:1997;248-250.